1. Home
  2. AVXL vs MGPI Comparison

AVXL vs MGPI Comparison

Compare AVXL & MGPI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AVXL
  • MGPI
  • Stock Information
  • Founded
  • AVXL 2001
  • MGPI 1941
  • Country
  • AVXL United States
  • MGPI United States
  • Employees
  • AVXL N/A
  • MGPI N/A
  • Industry
  • AVXL Biotechnology: Biological Products (No Diagnostic Substances)
  • MGPI Beverages (Production/Distribution)
  • Sector
  • AVXL Health Care
  • MGPI Consumer Staples
  • Exchange
  • AVXL Nasdaq
  • MGPI Nasdaq
  • Market Cap
  • AVXL 779.5M
  • MGPI 803.7M
  • IPO Year
  • AVXL N/A
  • MGPI 1988
  • Fundamental
  • Price
  • AVXL $8.35
  • MGPI $32.19
  • Analyst Decision
  • AVXL Strong Buy
  • MGPI Buy
  • Analyst Count
  • AVXL 2
  • MGPI 6
  • Target Price
  • AVXL $44.00
  • MGPI $70.67
  • AVG Volume (30 Days)
  • AVXL 995.5K
  • MGPI 327.8K
  • Earning Date
  • AVXL 02-12-2025
  • MGPI 02-26-2025
  • Dividend Yield
  • AVXL N/A
  • MGPI 1.50%
  • EPS Growth
  • AVXL N/A
  • MGPI 9.02
  • EPS
  • AVXL N/A
  • MGPI 4.82
  • Revenue
  • AVXL N/A
  • MGPI $737,717,000.00
  • Revenue This Year
  • AVXL N/A
  • MGPI N/A
  • Revenue Next Year
  • AVXL N/A
  • MGPI N/A
  • P/E Ratio
  • AVXL N/A
  • MGPI $6.67
  • Revenue Growth
  • AVXL N/A
  • MGPI N/A
  • 52 Week Low
  • AVXL $3.25
  • MGPI $31.81
  • 52 Week High
  • AVXL $14.44
  • MGPI $92.52
  • Technical
  • Relative Strength Index (RSI)
  • AVXL 40.39
  • MGPI 36.86
  • Support Level
  • AVXL $8.50
  • MGPI $32.12
  • Resistance Level
  • AVXL $9.20
  • MGPI $33.92
  • Average True Range (ATR)
  • AVXL 0.49
  • MGPI 1.00
  • MACD
  • AVXL -0.01
  • MGPI 0.16
  • Stochastic Oscillator
  • AVXL 32.23
  • MGPI 22.81

About AVXL Anavex Life Sciences Corp.

Anavex Life Sciences Corp is a clinical-stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system diseases with high unmet need. It analyzes genomic data from clinical studies to identify biomarkers, which are used to select patients that will receive the therapeutic benefit for the treatment of neurodegenerative and neurodevelopmental diseases. Its necessary compound ANAVEX 2-73 is being developed to treat Alzheimer's disease, Parkinson's disease, and potentially other central nervous system diseases, including rare diseases, such as Rett syndrome, a rare severe neurological monogenic disorder. The company's operating segment is into developing novel therapies for the management of CNS diseases.

About MGPI MGP Ingredients Inc.

MGP Ingredients Inc is a producer and supplier of premium distilled spirits and specialty wheat protein and starch food ingredients. MGP also produces high-quality industrial alcohol for use in both food and non-food applications. It operates in three segments: Distillery Solutions, Branded Spirits Segment, and Ingredient Solutions. Distillery Solutions provides distillery co-products, such as distillers feed, fuel grade alcohol, and corn oil: and warehouse services, including barrel put away, storage, and retrieval services. It derives most of its revenue from the Distillery Solutions segment.

Share on Social Networks: